Voluntary Transparency Beacon Discovery Optofluidic System

The University Medical Center Utrecht (UMC Utrecht) is planning to acquire the Beacon Discovery system from Bruker Cellular Analysis. This advanced cell selection device automates and accelerates the selection, cultivation, characterization, and sequencing of B-cells. Its purpose is to enable more efficient processing of cells and increase the likelihood of identifying promising therapeutic antibodies. The procurement, conducted via a negotiated procedure without prior publication of a call for competition, includes the purchase of the product itself, along with a maintenance contract, training, consumables, and disposables. This acquisition is part of the Biologics Workstream of Oncode Accelerator within UMC Utrecht, aiming to advance research in biologics and antibody discovery. The reference number for this voluntary transparency notice is not fully provided in the excerpt.

This is a supplies contract in the education and training sector. Located in Netherlands, Europe, this opportunity is open to firms and consortiums.

Published through Netherlands TenderNed, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the education and training sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.